Wolverine Trading’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Wolverine Trading's PBYI Position: Q2 2023 in Review
Wolverine Trading sold out of Puma Biotechnology (PBYI) in Q2 2023, closing a stake of 12,944 shares — an estimated $40.4K sold.
Wolverine Trading first reported a position in PBYI in Q2 2017 and held it in 16 quarters. The position peaked at $777K in Q2 2018. 68 funds tracked by Wall St. Rank hold PBYI as of Q2 2023.
- Wolverine Trading reported no remaining Puma Biotechnology position as of Q2 2023 after selling out during the quarter.
- Wolverine Trading sold 12,944 Puma Biotechnology shares in Q2 2023, an estimated $40.4K.
- Wolverine Trading first reported a position in Puma Biotechnology in Q2 2017 and held it in 16 quarters.
- Wolverine Trading's Puma Biotechnology position peaked at $777K in Q2 2018.
- 68 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2023.
Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.